Musikacharoen T et al. |
Histone acetylation and activation of cAMP-response element-binding protein regulate transcriptional activation of MKP-M in lipopolysaccharide-stimulated macrophages. |
2003 |
J. Biol. Chem. |
pmid:12511574
|
Haggarty SJ et al. |
Small molecule modulation of the human chromatid decatenation checkpoint. |
2003 |
Chem. Biol. |
pmid:14700634
|
Kim DK et al. |
Synthesis and biological evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new class of histone deacetylase inhibitors. |
2003 |
J. Med. Chem. |
pmid:14667227
|
Hong CY et al. |
Expression of MIS in the testis is downregulated by tumor necrosis factor alpha through the negative regulation of SF-1 transactivation by NF-kappa B. |
2003 |
Mol. Cell. Biol. |
pmid:12917325
|
Le Masson I et al. |
Yaf9, a novel NuA4 histone acetyltransferase subunit, is required for the cellular response to spindle stress in yeast. |
2003 |
Mol. Cell. Biol. |
pmid:12917332
|
Zhong S et al. |
Phosphorylation at serine 28 and acetylation at lysine 9 of histone H3 induced by trichostatin A. |
2003 |
Oncogene |
pmid:12917630
|
Kawai H et al. |
Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha. |
2003 |
Int. J. Cancer |
pmid:14506733
|
Lopatina NG et al. |
Control mechanisms in the regulation of telomerase reverse transcriptase expression in differentiating human teratocarcinoma cells. |
2003 |
Biochem. Biophys. Res. Commun. |
pmid:12810068
|
Liu LT et al. |
Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. |
2003 |
Cancer Res. |
pmid:12810630
|
Shin HJ et al. |
Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation. |
2003 |
Oncogene |
pmid:12813458
|
Hirose T et al. |
p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y. |
2003 |
Oncogene |
pmid:14586402
|
Brugarolas JB et al. |
TSC2 regulates VEGF through mTOR-dependent and -independent pathways. |
2003 |
Cancer Cell |
pmid:12957289
|
Cimini D et al. |
Histone hyperacetylation in mitosis prevents sister chromatid separation and produces chromosome segregation defects. |
2003 |
Mol. Biol. Cell |
pmid:12972566
|
Schuettengruber B et al. |
Autoregulation of mouse histone deacetylase 1 expression. |
2003 |
Mol. Cell. Biol. |
pmid:12972616
|
Bouchain G et al. |
Development of potential antitumor agents. Synthesis and biological evaluation of a new set of sulfonamide derivatives as histone deacetylase inhibitors. |
2003 |
J. Med. Chem. |
pmid:12593661
|
Castro-Galache MD et al. |
Susceptibility of multidrug resistance tumor cells to apoptosis induction by histone deacetylase inhibitors. |
2003 |
Int. J. Cancer |
pmid:12594812
|
Teyssier C et al. |
Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect. |
2003 |
Mol. Endocrinol. |
pmid:12554755
|
Noss KR et al. |
Methylation state of the prostate specific membrane antigen (PSMA) CpG island in prostate cancer cell lines. |
2002 May-Jun |
Anticancer Res. |
pmid:12168830
|
Rahman I et al. |
Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. |
2002 May-Jun |
Mol. Cell. Biochem. |
pmid:12162440
|
Iwata K et al. |
Trichostatin A, a histone deacetylase inhibitor, down-regulates interleukin-12 transcription in SV-40-transformed lung epithelial cells. |
2002 Jul-Aug |
Cell. Immunol. |
pmid:12470611
|
Sourlingas TG et al. |
The effect of the histone deacetylase inhibitor, trichostatin A, on total histone synthesis, H1(0) synthesis and histone H4 acetylation in peripheral blood lymphocytes increases as a function of increasing age: a model study. |
2002 Jan-Mar |
Exp. Gerontol. |
pmid:11772521
|
Inoue H et al. |
Histone deacetylase inhibitors sensitize human colonic adenocarcinoma cell lines to TNF-related apoptosis inducing ligand-mediated apoptosis. |
2002 |
Int. J. Mol. Med. |
pmid:11956660
|
Strait KA et al. |
Cell cycle blockade and differentiation of ovarian cancer cells by the histone deacetylase inhibitor trichostatin A are associated with changes in p21, Rb, and Id proteins. |
2002 |
Mol. Cancer Ther. |
pmid:12479699
|
Blagosklonny MV et al. |
Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity. |
2002 |
Mol. Cancer Ther. |
pmid:12481415
|
Drewell RA et al. |
Methylation-dependent silencing at the H19 imprinting control region by MeCP2. |
2002 |
Nucleic Acids Res. |
pmid:11861904
|
Murphy JC et al. |
Control of cytomegalovirus lytic gene expression by histone acetylation. |
2002 |
EMBO J. |
pmid:11867539
|
Kim JY et al. |
Probing lysine acetylation with a modification-specific marker ion using high-performance liquid chromatography/electrospray-mass spectrometry with collision-induced dissociation. |
2002 |
Anal. Chem. |
pmid:12433071
|
Elaut G et al. |
Major phase I biotransformation pathways of Trichostatin a in rat hepatocytes and in rat and human liver microsomes. |
2002 |
Drug Metab. Dispos. |
pmid:12433798
|
Yáñez RJ and Porter AC |
A chromosomal position effect on gene targeting in human cells. |
2002 |
Nucleic Acids Res. |
pmid:12433992
|
Park SH et al. |
Transcriptional regulation of the transforming growth factor beta type II receptor gene by histone acetyltransferase and deacetylase is mediated by NF-Y in human breast cancer cells. |
2002 |
J. Biol. Chem. |
pmid:11744689
|
Suenaga M et al. |
Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells. |
2002 |
Int. J. Cancer |
pmid:11807787
|
Gurova KV et al. |
Expression of prostate specific antigen (PSA) is negatively regulated by p53. |
2002 |
Oncogene |
pmid:11791186
|
Maeda Y et al. |
Repression of hepatocyte nuclear factor 4alpha tumor suppressor p53: involvement of the ligand-binding domain and histone deacetylase activity. |
2002 |
Mol. Endocrinol. |
pmid:11818510
|
Singal R et al. |
Methylation of promoter proximal-transcribed sequences of an embryonic globin gene inhibits transcription in primary erythroid cells and promotes formation of a cell type-specific methyl cytosine binding complex. |
2002 |
J. Biol. Chem. |
pmid:11684679
|
Nambiar MP et al. |
Effect of trichostatin A on human T cells resembles signaling abnormalities in T cells of patients with systemic lupus erythematosus: a new mechanism for TCR zeta chain deficiency and abnormal signaling. |
2002 |
J. Cell. Biochem. |
pmid:11967985
|
Fu M et al. |
Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. |
2002 |
Mol. Cell. Biol. |
pmid:11971970
|
Sirchia SM et al. |
Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer. |
2002 |
Cancer Res. |
pmid:11980632
|
Milutinovic S et al. |
Proliferating cell nuclear antigen associates with histone deacetylase activity, integrating DNA replication and chromatin modification. |
2002 |
J. Biol. Chem. |
pmid:11929879
|
Williams RS et al. |
A common mechanism of action for three mood-stabilizing drugs. |
2002 |
Nature |
pmid:12015604
|
Veilleux S and Boissonneault G |
Dynamics of reporter gene stimulation by HMG box proteins. |
2002 |
DNA Cell Biol. |
pmid:12015897
|
Huang HC et al. |
Geldanamycin inhibits trichostatin A-induced cell death and histone H4 hyperacetylation in COS-7 cells. |
2002 |
Life Sci. |
pmid:12002521
|
Scott GK et al. |
Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen. |
2002 |
Mol. Cancer Ther. |
pmid:12477051
|
Quivy V et al. |
Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies. |
2002 |
J. Virol. |
pmid:12368351
|
Smith WL and Edlind TD |
Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12384361
|
Harada K et al. |
Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. |
2002 |
Cancer Res. |
pmid:12384554
|
Zhang J et al. |
Establishment of transcriptional competence in early and late S phase. |
2002 |
Nature |
pmid:12432398
|
Kostyniuk CL et al. |
The ubiquitous and tissue specific promoters of the human SRC gene are repressed by inhibitors of histone deacetylases. |
2002 |
Oncogene |
pmid:12214274
|
Hall IM et al. |
Establishment and maintenance of a heterochromatin domain. |
2002 |
Science |
pmid:12215653
|
Lynch CA et al. |
Reactivation of a silenced H19 gene in human rhabdomyosarcoma by demethylation of DNA but not by histone hyperacetylation. |
2002 |
Mol. Cancer |
pmid:12234381
|
Hoshimoto A et al. |
Caprylic acid and medium-chain triglycerides inhibit IL-8 gene transcription in Caco-2 cells: comparison with the potent histone deacetylase inhibitor trichostatin A. |
2002 |
Br. J. Pharmacol. |
pmid:12010777
|